QIAGEN Receives Approval for EGFR Test in Lung Cancer as Companion Diagnostic in Japan
17 January 2019
QIAGEN N.V. today announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the therascreen® EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfi
